企業プロフィール
Catalent 株価・ニュース・カタリスト
- ティッカー:
- CTLT
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for CTLT.
企業概要
事業概要
Catalent was a pharmaceutical development and delivery company that supported drug formulation, manufacturing, and packaging before being acquired and taken private. It played a major role in outsourced pharma and biotech operations.
所在地とセクター分類
Catalent was headquartered in the United States and traded on NYSE before the acquisition. It sat in contract development and manufacturing rather than therapeutics.
ビジネスモデルの特徴
The company generated revenue from manufacturing, development, fill-finish, and delivery services for pharma customers. Investors historically watched outsourcing demand, production utilization, and margin recovery.
バイオ業界での位置付け
Catalent was a major infrastructure name for biotech and pharma, especially in manufacturing and delivery services. Because it has been acquired, it now belongs to historical sector infrastructure rather than the live public-company universe.
今後のカタリスト
- Catalent’s near-term catalysts are still transaction-related, with integration, divestiture, and site-rationalization milestones doing most of the work. That matters because demand only becomes valuable if the company can actually deliver at scale. Any improvement in supply or capacity can change how investors think about the next leg of the revenue curve.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。